Prime Medicine (PRME) Stock Price & Financial Analysis
Prime Medicine Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Prime Medicine
What is the current stock price for PRME?
As of the latest trading session, PRME stock trades at $3.23. The 52-week range is $2.02–$6.94, with a day range of $3.10–$3.37.
What is the P/E ratio for PRME?
The P/E ratio (Price-to-Earnings) for PRME is shown in the Key Statistics section. This valuation metric helps compare Prime Medicine, Inc. to industry peers.
Does PRME pay dividends?
Prime Medicine does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRME?
Based on 8 analysts, the consensus for PRME is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of PRME?
Prime Medicine's market capitalization is $572.0M, classifying it as a small-cap company. Prime Medicine operates in the Healthcare sector within the Biotechnology industry.